AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PROK
  4. [EFFECT] ProKidney Corp. SEC Filing

[EFFECT] ProKidney Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il seguente testo:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreibe den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il seguente testo:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreibe den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 7, 2025
Accession Number: 0001140361-25-024903
Submission Type: POS AM
CIK: 0001850270
Company Name: PROKIDNEY CORP.
File Number: 333-275701

Source:

Stock PROK logo
ProKidney

NASDAQ:PROK

PROK Rankings

#2944 Ranked by Market Cap
N/A Ranked by Dividends
#60 Top Gainer

PROK Latest News

Jul 8, 2025
ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
Jul 1, 2025
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
May 12, 2025
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights
Mar 17, 2025
ProKidney Reports Full Year 2024 Financial Results and Business Highlights
Jan 7, 2025
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PROK Latest SEC Filings

Jul 8, 2025
[144] ProKidney Corp. SEC Filing
Jul 8, 2025
[8-K] ProKidney Corp. Reports Material Event
Jul 8, 2025
[EFFECT] ProKidney Corp. SEC Filing
Jul 3, 2025
[S-8 POS] ProKidney Corp. SEC Filing
Jul 3, 2025
[S-8 POS] ProKidney Corp. SEC Filing

PROK Stock Data

76.70M
90.50M
27.17%
44.14%
9.33%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WINSTON-SALEM